GK

Gurpreet Kaur Puri

Active Director Whole-Time Director DIN 12027796
DIN 12027796 First appointment Oct 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Gurpreet Kaur Puri

Gurpreet Kaur Puri is a Whole-Time Director at Waterloo Pharmaceuticals Private Limited (since 2026).

DIN 12027796
Primary Designation Whole-Time Director
First Appointment 30 Oct 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director30 Oct 20262026Active

Board colleagues of Gurpreet Kaur Puri

NameDINCompanyDesignation
Mahika Kaur Bakshi12027797Waterloo Pharmaceuticals Private LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Waterloo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gurpreet Kaur Puri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurpreet Kaur Puri

Gurpreet Kaur Puri currently holds 1 directorship: Waterloo Pharmaceuticals Private Limited (Whole-Time Director, since 30 Oct 2026).

Gurpreet Kaur Puri was first appointed on 30 Oct 2026 as Whole-Time Director at Waterloo Pharmaceuticals Private Limited.

The current boards of Gurpreet Kaur Puri's companies include Mahika Kaur Bakshi (Waterloo Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available